BACE1 and early-onset autosomal dominant Alzheimer disease: Likewise, DL strongly inhibited cholinergic (AChE and BChE) and β-amyloid formation enzymes (BACE-1), thereby showing potential as an effective agent to control Alzheimer’s disease.